Tolvaptan PowerPoint PPT Presentations

UZMA MEHDI, M.D, MS NEPHROLOGY SALT Trial Pt were randomly assigned to placebo vs 15mg of tolvaptan Dose of tolvaptan was increased to 30mg and then to 60mg if necessary.

... and for the prevention of worsening hyponatremia ... Congestive Heart Failure Studies: Other PRO Endpoints ... Symptoms may vary depending on chronicity ...

Title: Slide 1 Author: chrisz Last modified by: Producer Created Date: 10/27/2006 1:45:46 PM Document presentation format: On-screen Show Company: OTSUKA

... NaCl 3% Per os: tolvaptan, satavaptan, lyxivaptan IV: ...

... agonist Terlipressin V1R antagonist Relcovaptan V1R /V2R antagonist Conivaptan V2R antagonist Mozavaptan V2R antagonist Tolvaptan Diseases Affecting the ...

... 15 mg Tolvaptan, 30 mg UOsm 650 UOsm 280 Neurosurgical SIADH V Hyponatremia in Heart Failure Increased sodium reabsorption in the kidney Angiotensin II ...

... B Ensayo A 7 d as o alta 4133 pts incluidos n=2048 n=2085 Ensayo a largo plazo Objetivo: morbilidad / mortalidad TOLVAPTAN. Bloqueante Vasopresina V2.

Thiazolidinediones interact with Abiraterone, Pixantrone, Azole Antifungals, Fibrates, Teriflunomide, Dabrafenib and Rifampin. Pioglitazone also interacts with Calcium channel blockers (Nifedipine, Amlodipine), Cobicistat, Piperaquine, Ifosfamide, Tolvaptan, Midazolam, Tipranavir/Ritonavir, Macrolide antibiotics, Sulphonamides, Amiodarone, Topiramate, Oral contraceptives, Atorvastatin, Danazol and Trandolapril.

Elimination or decreased need for fluid restriction ... Actions of Vasopressin. H2O retention. Hemostasis Vasodilation (high levels) Renal Tubule ...

SIADH AVP release is not fully suppressed as it would normally ... Gastroenterology 2003 RCT of 66 patients w/ cirrhosis ... Gastroenterology ...

Common electrolyte disorders in primary care ... Weight: Down OK ... Times New Roman Competition 1_Competition Common electrolyte ...

Anatomie des reins

... cause of hospitalization in elderly; 6% of all hospital admissions ... At least 40 days post-MI for ischemics. 3 months since diagnosis for non-ischemics ' ...

The Critically Ill Hyponatremic Patient: New Insights into Pharmacologic Management ... 2005;25:240-249. 3. Huda MSB et al. Postgrad Med J. 2006;82:216-219. ...

Jennifer Frontera, MD Medical Director Mount Sinai Neuro Science ICU * * * * Cardiac vascular or orthopedic surgery ...

no evidence of a survival benefit of continuous hemodiafiltration compared with intermittent dialysis continuous renal replacement therapies are probably ...

... Polyuria Polydipsia Nocturia Laboratory Findings Na 145 mEq/L Posm 285 mOsm/kg Uosm 3ml/kg/h low ...

Andexanet Alfa for Acute Major ... Myocardial infarction. ... In this preliminary report of an ongoing cohort study in patients with acute major bleeding ...

Promising Therapies. for Heart Failure. Gregg C. Fonarow, MD ... 1. Chen HH, Burnett JC. Curr Cardiol Rep. 2000;2:198-205. 2. Abraham WT et al. J Card Fail. ...

au Symposium sur invitation de l'Agence canadienne des m dicaments et ... Syndrome coronarien aigu, Accident vasculaire c r bral. Eculizumab (Soliris) ATC L04 ...

This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep track of these action items during your ...

Mean BNP Concentration (pg/ml) LV Dysfunction (n=14) 38 4. 141 31. 1076 ... BUN 24 mg/dl, sCr 1.5 mg/dl (baseline 1.2 mg/dl), WBC 21 K, pro-BNP 4,028 pg/ml ...

No tto previ amb trastuzumab o inhibidor d'aromatasa Pazopanib (O, AC) Carcinoma avan at de c l renals i amb tto pevia amb citoquina - 1a l nia, ...

Title: cardiovascular drugs and autacoids Subject: cardiovascular drugs and autacoids Author: ALHARBI Keywords: cardiovascular drugs and autacoids

OVERTURE. Cytokine antagonists. RENAISSANCE. RECOVER. Endothelin antagonists ... OVERTURE: ACE/NEP Inhibitors. in Heart Failure. Omapatrilat. Enalapril. P=0.187 ...

Acid-Base and Electrolyte Pearls Luis S. Gonzalez III, Pharm.D., BCPS Memorial Medical Center In the last year, pick your most frequently watched television program.

University of Southern California School of Medicine. Los Angeles, California ... Dilatation of afferent efferent renal arterioles leading to pressure ...

Jean Rouleau, MD FRCPC. Dean of the Faculty of Medicine, ... OVERTURE, 2003. RENAISSANCE, 2002. ENABLE-II, 2001. OPTIMAL, 2003. Vasodilator Hypothesis ...

1-Pituitary hormones(this).ppt

CARDIOPAT A ISQU MICA: 25 50% (muerte de miocitos) ... Barato. No invasivo. Repetible. Permite ver la causa. Permite establecer el. tipo de disfunci n. ...

SISTEMA ENDOCRINO Meccanismo di azione degli ormoni Caratteristiche degli Ormoni Recettori degli Ormoni Ipotalamo Ipotalamo Ipofisi Regolazione delle ghiandole ...